193 related articles for article (PubMed ID: 28137779)
21. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
22. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
Park J; Lee SB; Lee S; Kim Y; Song S; Kim S; Bae E; Kim J; Shong M; Kim JM; Chung J
Nature; 2006 Jun; 441(7097):1157-61. PubMed ID: 16672980
[TBL] [Abstract][Full Text] [Related]
24. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb.
Glasl L; Kloos K; Giesert F; Roethig A; Di Benedetto B; Kühn R; Zhang J; Hafen U; Zerle J; Hofmann A; de Angelis MH; Winklhofer KF; Hölter SM; Vogt Weisenhorn DM; Wurst W
Exp Neurol; 2012 May; 235(1):214-27. PubMed ID: 22265660
[TBL] [Abstract][Full Text] [Related]
25. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.
Azkona G; López de Maturana R; Del Rio P; Sousa A; Vazquez N; Zubiarrain A; Jimenez-Blasco D; Bolaños JP; Morales B; Auburger G; Arbelo JM; Sánchez-Pernaute R
Mol Neurobiol; 2018 Jan; 55(1):506-516. PubMed ID: 27975167
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
Hoepken HH; Gispert S; Morales B; Wingerter O; Del Turco D; Mülsch A; Nussbaum RL; Müller K; Dröse S; Brandt U; Deller T; Wirth B; Kudin AP; Kunz WS; Auburger G
Neurobiol Dis; 2007 Feb; 25(2):401-11. PubMed ID: 17141510
[TBL] [Abstract][Full Text] [Related]
27. Lysine desuccinylase SIRT5 binds to cardiolipin and regulates the electron transport chain.
Zhang Y; Bharathi SS; Rardin MJ; Lu J; Maringer KV; Sims-Lucas S; Prochownik EV; Gibson BW; Goetzman ES
J Biol Chem; 2017 Jun; 292(24):10239-10249. PubMed ID: 28458255
[TBL] [Abstract][Full Text] [Related]
28. The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway.
Gao F; Chen D; Si J; Hu Q; Qin Z; Fang M; Wang G
Hum Mol Genet; 2015 May; 24(9):2528-38. PubMed ID: 25612572
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
[TBL] [Abstract][Full Text] [Related]
30. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
[TBL] [Abstract][Full Text] [Related]
31. Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus.
Agnihotri SK; Shen R; Li J; Gao X; Büeler H
FASEB J; 2017 Jul; 31(7):2839-2853. PubMed ID: 28325755
[TBL] [Abstract][Full Text] [Related]
32. Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons.
Zhou ZD; Refai FS; Xie SP; Ng SH; Chan CH; Ho PG; Zhang XD; Lim TM; Tan EK
Free Radic Biol Med; 2014 Mar; 68():220-33. PubMed ID: 24374372
[TBL] [Abstract][Full Text] [Related]
33. Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy.
Liu J; Wang X; Lu Y; Duan C; Gao G; Lu L; Yang H
Cell Death Dis; 2017 Sep; 8(9):e3056. PubMed ID: 28933786
[TBL] [Abstract][Full Text] [Related]
34. Shared and cell type-specific mitochondrial defects and metabolic adaptations in primary cells from PINK1-deficient mice.
Akundi RS; Zhi L; Sullivan PG; Büeler H
Neurodegener Dis; 2013; 12(3):136-49. PubMed ID: 23295771
[TBL] [Abstract][Full Text] [Related]
35. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.
Wang HL; Chou AH; Wu AS; Chen SY; Weng YH; Kao YC; Yeh TH; Chu PJ; Lu CS
Biochim Biophys Acta; 2011 Jun; 1812(6):674-84. PubMed ID: 21421046
[TBL] [Abstract][Full Text] [Related]
36. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
[TBL] [Abstract][Full Text] [Related]
37. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
38. Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models.
Lee KS; Huh S; Lee S; Wu Z; Kim AK; Kang HY; Lu B
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8844-E8853. PubMed ID: 30185553
[TBL] [Abstract][Full Text] [Related]
39. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
40. Mobility and function of coenzyme Q (ubiquinone) in the mitochondrial respiratory chain.
Lenaz G; Genova ML
Biochim Biophys Acta; 2009 Jun; 1787(6):563-73. PubMed ID: 19268424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
